Drug · DIN 02365715
FLUZONE
INFLUENZA VIRUS VACCINE TRIVALENT TYPES A & B (SPLIT VIRION). 0.5ML SINGLE-DOSE VIAL - PRESERVATIVE-FREE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since December 21, 2016.
- Drug Identification Number (DIN)
- 02365715
- Company (DIN owner)
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Schedule
- Schedule d
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HAEMAGGLUTININ-STRAIN A (H1N1) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN A (H3N2) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B | 15 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 22, 2011: NOC 12207New Drug Submission (NDS)
Other DINs named FLUZONE
- DIN 02365707 · Marketed
- DIN 02365936 · Marketed
- DIN 02365693 · Cancelled Pre Market